A case of cholestatic hepatitis associated with D-penicillamine therapy for rheumatoid arthritis. 1985

J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes

A male aged 72 years suffering from erosive seropositive rheumatoid arthritis developed jaundice after one month on D-penicillamine after a cumulative dose of 5.625 g. The biological abnormalities were characteristic of cholestasis. There were no gall-stones. The liver biopsy showed severe intrahepatocellular cholestasis with a slight degree of cellular cholangitis and with eosinophils in the portal tracts. There was no sign of cellular necrosis. After cessation of D-penicillamine, the jaundice cleared within three weeks and the enzymes were normalized within two months. The aetiology is discussed and the cases of the literature are reviewed. This case represents a further instance of D-penicillamine-induced cholestatic hepatitis.

UI MeSH Term Description Entries
D008297 Male Males
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D002780 Cholestasis, Intrahepatic Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC). Bile Duct Obstruction, Intrahepatic,Biliary Stasis, Intrahepatic,Intrahepatic Cholestasis,Biliary Stases, Intrahepatic,Cholestases, Intrahepatic,Intrahepatic Biliary Stases,Intrahepatic Biliary Stasis,Intrahepatic Cholestases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
April 1979, Canadian Medical Association journal,
J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
January 1985, Clinical and experimental rheumatology,
J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
January 1985, Scandinavian journal of rheumatology,
J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
January 1977, Proceedings of the Royal Society of Medicine,
J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
January 1979, Scandinavian journal of rheumatology. Supplement,
J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
June 1982, Arerugi = [Allergy],
J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
January 1978, Reumatizam,
J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
September 1993, Nihon Kyobu Shikkan Gakkai zasshi,
J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
February 1988, Revista espanola de las enfermedades del aparato digestivo,
J P Devogelaer, and J P Huaux, and E Coche, and J Rahier, and C Nagant de Deuxchaisnes
April 1998, British journal of rheumatology,
Copied contents to your clipboard!